# 10x Genomics

Type: Company (TXG)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/10x-genomics
Canonical HTML page: https://getbiobrief.com/entity/10x-genomics

## Timeline

- **2026-03-06**: JPMorgan Disclosure — JPMorgan Chase & Co. reveals its $12.55 million position in the company.
- **2026-02-25**: Insider Activity — CEO Serge Saxonov sells 9,632 shares under a standard trading plan.
- **2026-02-22**: Syon Capital Entry — Syon Capital LLC discloses a new stake in TXG, adding to institutional support.
- **2026-02-20**: Market Momentum — 10x Genomics shares trade up 6.4% as market sentiment begins to shift.

## Recent coverage (1 stories)

### JPMorgan Discloses $12.55M Stake in 10x Genomics Amid Sector Volatility
2026-03-06 11:03:38 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

JPMorgan Chase & Co. has established a significant $12.55 million position in 10x Genomics, signaling institutional confidence in the spatial biology leader. This move comes as the biotech tools sector navigates a complex landscape of patent litigation and shifting R&D budgets.
Full story: https://getbiobrief.com/story/jpmorgan-stake-10x-genomics-txg-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.